Log In
Print
BCIQ
Print
Print this Print this
 

CEP-9722

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionPoly(ADP-ribose) polymerase (PARP) inhibitor
Molecular Target Poly(ADP-ribose) polymerase (PARP)
Mechanism of ActionPoly(ADP-ribose) polymerase (PARP) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today